RACHEAL JERNIGAN: Open Payments
NPI 1710136528 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$137 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $137
Food & beverage: $137
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 2 | $47 |
| Abbott Laboratories | 2 | $44 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $13 |
Products named: FUROSCIX, CARDIOMEMS, AMVUTTRA, FARXIGA, JARDIANCE.
Industry payments across SC — which companies pay providers there.
